Last reviewed: June 15, 2026
Last updated: June 15, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists like semaglutide have emerged as powerful tools for cardiovascular protection in patients with obesity and metabolic disease. The SUSTAIN-6 trial demonstrated a 26% reduction in major adverse cardiac events among semaglutide users, a finding that transformed how clinicians view weight-loss medications. Beyond the scale, semaglutide actively improves the biological systems that protect your heart.
How Semaglutide Protects Your Cardiovascular System
Semaglutide works through multiple pathways that directly benefit heart health. When you activate the GLP-1 receptor, your body responds by improving insulin sensitivity, stabilizing blood sugar, and reducing inflammation throughout your arterial system. These changes work together to lower blood pressure and decrease the buildup of cholesterol in vessel walls—two of the primary drivers of heart disease progression.
The medication also improves how your heart muscle functions. Research shows semaglutide users experience better left ventricular function and reduced strain on the heart chambers. Weight loss amplifies these benefits; losing even 5-10% of body weight significantly decreases the workload your heart must manage with each beat, improving long-term cardiac efficiency.
Cardiovascular Benefits Proven in Large Clinical Trials
The SUSTAIN-6 trial followed over 3,000 patients with type 2 diabetes for nearly two years and found semaglutide reduced the composite endpoint of heart attack, stroke, and cardiovascular death by 26% compared to placebo. This landmark result earned semaglutide recognition as a cardioprotective medication, not simply a weight-loss agent. Patients also experienced reductions in hospitalization for heart failure and improvements in kidney function.
Subsequent trials have reinforced these findings across different patient populations. The SELECT trial, which examined semaglutide in people without diabetes but with obesity and established heart disease or multiple cardiac risk factors, showed a 20% reduction in major adverse cardiovascular events. These results demonstrate that cardiovascular benefits appear across diverse groups, making semaglutide relevant for anyone concerned about heart health and metabolic disease.
Blood Pressure, Cholesterol, and Metabolic Improvements
Semaglutide reduces systolic blood pressure by an average of 5-10 mmHg in clinical studies, a reduction that translates to meaningful protection against future heart attacks and strokes. The medication simultaneously improves lipid profiles by reducing triglycerides and lowering LDL cholesterol while preserving beneficial HDL levels. These metabolic shifts address multiple risk factors simultaneously, which is why single-medication approaches often fail at cardiovascular protection.
The medication's effect on weight loss amplifies these metabolic benefits. Each kilogram of weight lost reduces systemic inflammation markers like C-reactive protein, which damages arterial linings and promotes plaque formation. Patients using semaglutide report sustained weight reduction that compounds cardiovascular improvements month after month, creating a powerful cascade of health benefits that extend far beyond the initial medication response.
Personalized Semaglutide Therapy at PlexusDx
PlexusDx offers compounded semaglutide injections starting at $149 per month through licensed 503A compounding pharmacies available in all 50 states. The flat monthly pricing means your dose can be adjusted upward without additional cost—a structure designed to accommodate individual metabolic needs while protecting your budget. HSA and FSA funds cover semaglutide treatments, making precision cardiovascular therapy more accessible than traditional prescription models.
Patients interested in understanding their individual response potential can add the PlexusDx Precision Peptide Genetic Test ($99) after their first month of treatment. This test analyzes genetic variants in the GLP1R, GIPR, FTO, and MC4R pathways—key genes controlling appetite, metabolic rate, and cardiac response to GLP-1 therapy. Understanding your genetic profile helps optimize dosing strategy and predict the magnitude of cardiovascular and metabolic benefits you're likely to experience.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Will semaglutide lower my blood pressure and cholesterol?
Clinical trials show semaglutide reduces systolic blood pressure by 5-10 mmHg and improves lipid profiles by lowering triglycerides and LDL cholesterol. These improvements work alongside weight loss to reduce overall cardiovascular disease risk across multiple pathways.
What did the SUSTAIN-6 trial prove about semaglutide and heart disease?
SUSTAIN-6 demonstrated a 26% reduction in major adverse cardiac events (heart attack, stroke, cardiovascular death) in semaglutide users compared to placebo. This landmark trial established semaglutide as a cardioprotective medication approved for reducing cardiovascular risk in high-risk patients.
How much does compounded semaglutide cost at PlexusDx?
PlexusDx compounded semaglutide injections start at $149 per month with flat pricing across all dose levels. The service covers all 50 states with no insurance requirement, and HSA/FSA funds are accepted.
Are there side effects when using semaglutide for heart health?
Common side effects include nausea, constipation, and reduced appetite—typically mild and transient as your body adjusts. Serious side effects are rare but can include pancreatitis; discuss your full medical history with your care provider before starting treatment.
How does the PlexusDx Precision Peptide Genetic Test help with semaglutide therapy?
The genetic test analyzes GLP1R, GIPR, FTO, and MC4R variants to predict your individual metabolic response and cardiovascular benefit potential. This personalization helps optimize your dosing strategy for maximum heart-protective outcomes at PlexusDx.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Do People Lose Weight So Fast on Ozempic?
How Long Will Ozempic Side Effects Last? Understanding Duration and Management